October 17, 2012
Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine
March 8, 2012
Reagent Proteins Establishes Distribution Agreement with Cambridge BioScience
March 1, 2012
Pfenex Inc. and DNA2.0 Collaborate on Protein Expression Technology
January 10, 2012
Pfenex Inc. and Prozyme Establish Joint Collaboration and Supply Agreement
September 6, 2011
FierceBiotech Names Pfenex a 2011 Fierce 15 Biotech
August 3, 2011
Reagent Proteins Establishes Exclusive Distrbution Agreement In Japan With Funakoshi Co. LTD.
June 7, 2011
Pfenex Inc. Announces Strategic Agreement with SAFC
June 1, 2011
Reagent Proteins, A Division of Pfenex Inc., Announce the Commercial Launch of Full Length Circumsporozoite Protein (CSP)
May 17, 2011
Pfenex Inc., through its Reagent Proteins Business Division announces submission of Biologics Master File for Recombinant CRM197 to US FDA
March 30, 2011
Reagent Proteins' Launches New eCommerce Site
February 23, 2011
Pfenex Inc., through its Reagent Proteins Business Division, establishes limited-purpose CRADA with the Naval Medical Research Center and HJF
February 15, 2011
Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the use of Pfēnex Expression Technology™
January 26, 2011
Pfenex Inc. awarded sub-contract by Science Applications International Corporation (SAIC) to help develop a scalable production process based on Pfēnex Expression Technology™ for a key Malaria antigen
January 7, 2011
Reagent Proteins to make Conference Exhibiting Debut and Dr. Diane Retallack to Speak at the 10th Annual Pep Talk Conference
November 30, 2010
Reagent Proteins, a division of Pfenex Inc. signs cGMP CRM197 Clinical Supply Agreement with Henry M. Jackson Foundation
November 2, 2010
Pfenex Inc. Launches ReagentProteins.com
August 24, 2010
Pfenex Inc. Establishes Reagent Protein Distribution Agreement with Cedarlane Corporation
August 3, 2010
Pfenex Inc. Announces Contract Award of up to $18.8 million from HHS BARDA for Development of an Anthrax Vaccine
Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine
March 8, 2012
Reagent Proteins Establishes Distribution Agreement with Cambridge BioScience
March 1, 2012
Pfenex Inc. and DNA2.0 Collaborate on Protein Expression Technology
January 10, 2012
Pfenex Inc. and Prozyme Establish Joint Collaboration and Supply Agreement
September 6, 2011
FierceBiotech Names Pfenex a 2011 Fierce 15 Biotech
August 3, 2011
Reagent Proteins Establishes Exclusive Distrbution Agreement In Japan With Funakoshi Co. LTD.
June 7, 2011
Pfenex Inc. Announces Strategic Agreement with SAFC
June 1, 2011
Reagent Proteins, A Division of Pfenex Inc., Announce the Commercial Launch of Full Length Circumsporozoite Protein (CSP)
May 17, 2011
Pfenex Inc., through its Reagent Proteins Business Division announces submission of Biologics Master File for Recombinant CRM197 to US FDA
March 30, 2011
Reagent Proteins' Launches New eCommerce Site
February 23, 2011
Pfenex Inc., through its Reagent Proteins Business Division, establishes limited-purpose CRADA with the Naval Medical Research Center and HJF
February 15, 2011
Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the use of Pfēnex Expression Technology™
January 26, 2011
Pfenex Inc. awarded sub-contract by Science Applications International Corporation (SAIC) to help develop a scalable production process based on Pfēnex Expression Technology™ for a key Malaria antigen
January 7, 2011
Reagent Proteins to make Conference Exhibiting Debut and Dr. Diane Retallack to Speak at the 10th Annual Pep Talk Conference
November 30, 2010
Reagent Proteins, a division of Pfenex Inc. signs cGMP CRM197 Clinical Supply Agreement with Henry M. Jackson Foundation
November 2, 2010
Pfenex Inc. Launches ReagentProteins.com
August 24, 2010
Pfenex Inc. Establishes Reagent Protein Distribution Agreement with Cedarlane Corporation
August 3, 2010
Pfenex Inc. Announces Contract Award of up to $18.8 million from HHS BARDA for Development of an Anthrax Vaccine
Advanced Search
|
